Insider · CIK 0001595041
Kathryn Quadracci Flores
Files at QUAD (Quad/Graphics, Inc.). First filing -, latest -.
Kathryn Quadracci Flores files SEC Form 4 as director at QUAD (Quad/Graphics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kathryn Quadracci Flores has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 22, 2026 | QUAD Quad/Graphics, Inc. | 27,427 0.07% of outstanding | $197k | May 22, 2026 | $135k |
| May 1, 2026 | QUAD Quad/Graphics, Inc. | 7,675 0.02% of outstanding | $57k | May 1, 2026 | $149k |
| Mar 6, 2026 | QUAD Quad/Graphics, Inc. | 10,655 0.03% of outstanding | $73k | Mar 6, 2026 | $78k |
| Feb 19, 2026 | QUAD Quad/Graphics, Inc. | 11,633 0.03% of outstanding | $79k | Feb 20, 2026 | none |
| May 22, 2025 | QUAD Quad/Graphics, Inc. | 38,496 0.10% of outstanding | $216k | May 22, 2025 | $61k |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -17,735 | $7.25 | $129k | 84,005 | May 28, 2026 |
| May 27, 2026 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -9,692 | $7.40 | $72k | 74,313 | May 28, 2026 |
| May 20, 2026 | QUAD Quad/Graphics, Inc. | AGrant or award Class A Common Stock | +19,178 | $0.00 | $0 | 101,740 | May 22, 2026 |
| May 1, 2026 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -7,675 | $8.30 | $64k | 82,562 | May 5, 2026 |
| Mar 6, 2026 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -10,655 | $6.65 | $71k | 89,363 | Mar 9, 2026 |
| Mar 1, 2026 | QUAD Quad/Graphics, Inc. | FTax withholding Class A Common Stock | -7,232 | $6.91 | $50k | 100,018 | Mar 3, 2026 |
| Feb 20, 2026 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -11,633 | $6.74 | $78k | 107,250 | Feb 23, 2026 |
| Jan 1, 2026 | QUAD Quad/Graphics, Inc. | AGrant or award Class A Common Stock | +11,244 | $0.00 | $0 | 118,883 | Jan 5, 2026 |
| May 28, 2025 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -38,496 | $5.83 | $224k | 105,133 | May 30, 2025 |
| May 21, 2025 | QUAD Quad/Graphics, Inc. | AGrant or award Class A Common Stock | +22,004 | $0.00 | $0 | 143,629 | May 23, 2025 |
| May 16, 2025 | QUAD Quad/Graphics, Inc. | DDisposition to issuer Class A Common Stock | -10,484 | $5.83 | $61k | 121,625 | May 19, 2025 |
| Mar 1, 2025 | QUAD Quad/Graphics, Inc. | FTax withholding Class A Common Stock | -7,164 | $6.28 | $45k | 130,994 | Mar 4, 2025 |
| Jan 1, 2025 | QUAD Quad/Graphics, Inc. | AGrant or award Class A Common Stock | +8,209 | $0.00 | $0 | 138,158 | Jan 3, 2025 |
Questions about Kathryn Quadracci Flores
Answered from the filings on this page, as of the latest one.
Is Kathryn Quadracci Flores buying or selling?
Kathryn Quadracci Flores has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kathryn Quadracci Flores's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathryn Quadracci Flores has 0.
Where does Kathryn Quadracci Flores file Form 4?
Kathryn Quadracci Flores has filed Form 4 at QUAD (Quad/Graphics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.